在擴大呼吸機產品生產線的行動中，ResMed集團達成協議獲得Saimie SA公司，股權和債務大約為109百萬美元。

尤其是ResMed達成協議獲得Financiere ACE SAS，這是Saime SA及其附屬機構的控股公司。ResMed與Saime自從1996年就有了長期合作關系，當時ResMed從Saime集團購買了第一個法國睡眠治療配送財產。從1987年開始，Saime已經研制開發了系列完整的家用和醫院使用的呼吸機。在法國和德國該公司將其產品直接銷售，在歐洲和亞洲太平洋地區則通過銷售網絡進行分銷。

ResMed主席兼首席執行官Peter C.Farrell博士評論說：“獲得Saime公司將完善我們的家用呼吸機產品生產線，并能夠迅速擴大我們的市場，以及在歐洲和其它地區的銷售網絡。VS和Elisee系列產品是尖端產品，但是能夠十分便于醫生、臨床工作人員和患者的使用。我們相信，這些設備將補充我們的VPAP III和AutoSet CS設備，使得我們能夠為需要呼吸輔助設備的患者提供完整的選擇?！?/P>

ResMed公司是生產用于睡眠呼吸障礙以及其它呼吸疾病治療和控制的醫療設備領先制造商。
 
ResMed to Acquire Ventilator Company
 
In a move to enlarge its line of ventilation products, ResMed, Inc. (San Diego, CA, USA) has agreed to acquire Saimie SA (Savigny le Temple, France) for about U.S.$109 million in equity and debt.

Specifically, ResMed has agreed to acquire Financiere ACE SAS, the holding company for Saime SA and its affiliates. ResMed and Saime have had a long-standing relationship since 1996, when ResMed bought its first French sleep therapy distribution assets from the Saime group. Since its formation in 1987, Saime has developed a complete range of ventilators for use in the home and hospital markets. The company distributes its products directly in France and Germany and through a network of distributors in Europe and Asia-Pacific.

“The acquisition of Saime will complete our line of homecare ventilation products and immediately expand our market presence and distribution network in Europe and other regions,” commented Peter C. Farrell, Ph.D., chairman and CEO of ResMed. “The VS and Elisee range of products are sophisticated yet easy to use for physicians, clinicians, and patients. We believe these devices will complement our VPAP III and AutoSet CS devices and will allow us to provide the full range of options for patients who need ventilatory assistance.”

ResMed is a leading manufacturer of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders.